Home/Filings/4/0001683168-20-000016
4//SEC Filing

Versavel Mark 4

Accession 0001683168-20-000016

CIK 0001638287other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 9:54 PM ET

Size

9.3 KB

Accession

0001683168-20-000016

Insider Transaction Report

Form 4
Period: 2019-12-30
Versavel Mark
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-12-30+45,72445,724 total
    Exercise: $0.63Exp: 2029-01-31Common Stock (45,724 underlying)
  • Award

    Stock Option (right to buy)

    2019-12-30+297,206297,206 total
    Exercise: $0.63Exp: 2029-01-28Common Stock (297,206 underlying)
Footnotes (4)
  • [F1]70,000 shares underlying the option shall become vested shares upon certain milestones in relation to the Issuer's the Phase III US NB-01-301 study; 60,000 shares underlying the option shall become vested shares upon certain regulatory milestones related to the Issuer's product candidate,NB-02; an additional 70,000 option shares shall become vested shares upon the occurrence of certain additional milestones related to the Issuer's Phase III US NB-01-301; 15,000 shares underlying the option became vested shares on January 28, 2019; and an additional 7,500 of shares underlying the option became vested share on each of February 1, 2019, May 1, 2019, August 1, 2019, and November 1, 2019, with an additional 7,500 shares underlying the option to vest on each of February 1, 2020 and May 1, 2020.
  • [F2]Reflects the Reporting Person's stock option to acquire 260,000 shares of private NeuroBo Pharmaceuticals, Inc. ("NeuroBo") common stock for $0.72 per share that was assumed by the Issuer in the Merger.
  • [F3]10,000 shares underlying the option became a vested share on the January 31, 2019, with an additional 5,000 shares vesting on each of February 1, 2019, May 1, 2019, August 1, 2019, November 1, 2019, February 1, 2020 and May 1, 2020.
  • [F4]Reflects the Reporting Person's stock option to acquire 40,000 shares of NeuroBo common stock for $0.72 per share that was assumed by the Issuer in the Merger.

Documents

1 file

Issuer

NeuroBo Pharmaceuticals, Inc.

CIK 0001638287

Entity typeother

Related Parties

1
  • filerCIK 0001795795

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 9:54 PM ET
Size
9.3 KB